Galmed Pharmaceuticals (GLMD) Other financing activities (2016 - 2020)
Galmed Pharmaceuticals (GLMD) posted quarterly Other financing activities of $61000.0 for Q1 2020, down 17.57% year-over-year from $74000.0 in Q2 2019, and up 27.08% quarter-over-quarter from $48000.0 in Q4 2019.
Galmed Pharmaceuticals (GLMD) Other financing activities (2016 - 2020) Analysis & Trends
Galmed Pharmaceuticals' Other financing activities history runs 5 years deep, the most recent figure standing at $61000.0 for Q1 2020.
- In Q1 2020, Other financing activities fell 17.57% year-over-year to $61000.0; the TTM figure through Dec 2020 stood at $61000.0 (down 57.34% YoY), while the FY2025 annual figure was $2.0 million, up 249.21% from the prior year.
- Other financing activities for Q1 2020 stood at $61000.0, up from $48000.0 in the prior quarter.
- The five-year high for Other financing activities was $868000.0 in Q2 2018, with the low at $11000.0 in Q2 2016.
- The 5-year median for Other financing activities is $64500.0 (2017), against an average of $160250.0.
- Peak annual rise in Other financing activities reached 516.67% in 2019, while the deepest fall reached 97.58% in 2019.
- Galmed Pharmaceuticals' Other financing activities stood at $398000.0 in 2016, then tumbled by 45.48% to $217000.0 in 2017, then sank by 61.29% to $84000.0 in 2018, then plunged by 42.86% to $48000.0 in 2019, then gained by 27.08% to $61000.0 in 2020.
- Business Quant data shows GLMD's Other financing activities at $61000.0 in Q1 2020, $48000.0 in Q4 2019, and $21000.0 in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Galmed Pharmaceuticals | 2.39 Mn | -9.49 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 61,000.00 |
| Mar 31, 2020 | 61,000.00 |
| Dec 31, 2019 | 48,000.00 |
| Dec 31, 2019 | 48,000.00 |
| Jun 30, 2019 | 21,000.00 |
| Jun 30, 2019 | 21,000.00 |
| Mar 31, 2019 | 74,000.00 |
| Mar 31, 2019 | 74,000.00 |
| Dec 31, 2018 | 84,000.00 |
| Dec 31, 2018 | 84,000.00 |
| Sep 30, 2018 | 63,000.00 |
| Sep 30, 2018 | 63,000.00 |
| Jun 30, 2018 | 868,000.00 |
| Jun 30, 2018 | 868,000.00 |
| Mar 31, 2018 | 12,000.00 |
| Mar 31, 2018 | 12,000.00 |
| Dec 31, 2017 | 217,000.00 |
| Dec 31, 2017 | 217,000.00 |
| Sep 30, 2017 | 66,000.00 |
| Sep 30, 2017 | 66,000.00 |